Clinical trial · Interventional
Myo-inositol Versus Metformin in Patients With Polycystic Ovarian Syndrome to Treat Obesity
Comparison of Myo-inositol Versus Metformin for Treating Obesity in Patients With Polycystic Ovarian Syndrome
NCT07387679CI-TRIAL-00102333completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
There are considerable gaps in the comparative effectiveness and tolerability of myo-inositol and metformin for treating obesity in patients with polycystic ovarian syndrome (PCOS). The current study aimed to give insights comparing myo-inositol versus metformin for treating obesity in patients with PCOS.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Polycystic Ovarian Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Metformin | Drug | Metformin | ALIAS |
| Myo-inositol | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group-A
- description
- Women were given tablet myo-inositol 1 gm twice a day for 3 months.
- interventionNames
- Drug: Myo-inositol
- type
- EXPERIMENTAL
- label
- Group-B
- description
- Women received metformin 250 mg three times daily for 3 months.
- interventionNames
- Drug: Metformin
Primary outcomes (1)
- measure
- Reduction in body mass index
- timeFrame
- 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Females aged 18-45 years * Diagnosed case of PCOS for more than 6 months of duration Exclusion Criteria: * Women with hyperprolactinemia or hypothyroidism (on history \& medical record review) * Adrenal hyperplasia or Cushing's syndrome (on history \& medical record review)
References
Publications (0)
Data not yet available
No reference posted for this study.